[1]S. Zuo, W. Al Rawashdeh, S. Rosenhain, Z. Magnuska, Y. G. Gyamfuah, F. Kießling, F. Gremse,
"Mixing Matrix-corrected Whole-body Pharmacokinetic Modeling Using Longitudinal Micro-computed Tomography and Fluorescence-mediated Tomography", Molecular imaging & biology, 2021.
[bibtex] [url] [doi]
[2]T. Wirtz, A. Saal, I. Bergmann, P. Fischer, D. Heinrichs, E. F. Brandt, M. T. Koenen, S. Djudjaj, K. M. Schneider, P. Boor, R. Bucala, R. Weiskirchen, J. Bernhagen, C. Trautwein, M. Berres,
"Macrophage migration inhibitory factor exerts pro‐proliferative and anti‐apoptotic effects via CD74 in murine hepatocellular carcinoma", British journal of pharmacology, vol. 178, no. 22, 2021, pp. 4452–4467.
[bibtex] [url] [doi]
[3]T. Wirtz, P. A. Reuken, C. Jansen, P. Fischer, I. Bergmann, C. Backhaus, C. Emontzpohl, J. Reißing, E. F. Brandt, M. T. Koenen, K. M. Schneider, R. Schierwagen, M. J. Brol, J. Chang, H. W. Zimmermann, N. Köse-Vogel, T. Eggermann, I. Kurth, C. Stoppe, R. Bucala, J. Bernhagen, M. Praktiknjo, A. Stallmach, C. Trautwein, J. Trebicka, T. Bruns, M. Berres,
"Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis", JHEP reports, vol. 3, no. 2, 2021, pp. 100221.
[bibtex] [url] [doi]
[4]Y. Wen, J. Lambrecht, C. Ju, F. Tacke,
"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities", Cellular & molecular immunology, vol. 18, no. 1, 2021, pp. 45–56.
[bibtex] [url] [doi]
[5]C. Wagner, N. Torow, M. W. Hornef, H. Lelouard,
"Spatial and temporal key steps in early-life intestinal immune system development and education", The FEBS journal, 2021.
[bibtex] [url] [doi]
[6]J. Voss, C. V. Schneider, M. Kleinjans, T. Bruns, C. Trautwein, P. Strnad,
"Hepatobiliary phenotype of individuals with chronic intestinal disorders", Scientific reports, vol. 11, no. 1, 2021, pp. 19954.
[bibtex] [url] [doi]
[7]J. Trebicka, P. Bork, A. Krag, M. Arumugam,
"Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure", Nature reviews / Gastroenterology & hepatology, vol. 18, no. 3, 2021, pp. 167–180.
[bibtex] [url] [doi]
[8]J. Trebicka, J. Macnaughtan, B. Schnabl, D. L. Shawcross, J. S. Bajaj,
"The microbiota in cirrhosis and its role in hepatic decompensation", Journal of hepatology, vol. 75, no. Supplement 1, 2021, pp. S67–S81.
[bibtex] [url] [doi]
[9]S. Torres, M. J. Brol, F. Magdaleno, R. Schierwagen, F. E. Uschner, S. Klein, C. Ortiz, O. Tyc, N. Bachtler, J. Stunden, D. Bertheloot, A. Kitanovic, B. Sanchez, J. Schrum, W. R. Roush, L. Franchi, K. Byth, E. Latz, J. Trebicka,
"The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis", Frontiers in molecular biosciences, vol. 8, 2021, pp. 715765.
[bibtex] [url] [doi]
[10]F. Tacke, R. Weiskirchen,
"Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis", Annals of translational medicine, vol. 9, no. 8, 2021, pp. 729.
[bibtex] [url] [doi]
[11]T. Streidl, I. Karkossa, R. R. Segura Muñoz, C. Eberl, A. Zaufel, J. Plagge, R. Schmaltz, K. Schubert, M. Basic, K. M. Schneider, M. Afify, C. Trautwein, R. H. Tolba, B. Stecher, H. L. Doden, J. M. Ridlon, J. Ecker, T. Moustafa, M. von Bergen, A. E. Ramer-Tait, T. Clavel,
"The gut bacterium Extibacter muris produces secondary bile acids and influences liver physiology in gnotobiotic mice", Gut microbes, vol. 13, no. 1, 2021, pp. 1–21.
[bibtex] [url] [doi]
[12]C. Seikrit, O. Pabst,
"The immune landscape of IgA induction in the gut", Seminars in immunopathology, vol. 43, no. 5, 2021, pp. 627–637.
[bibtex] [url] [doi]
[13]K. M. Schneider, C. Elfers, A. Ghallab, C. V. Schneider, E. J. C. Galvez, A. Mohs, W. Gui, L. S. Candels, T. Wirtz, S. Zuehlke, M. Spiteller, M. Myllys, A. Roulet, A. Ouzerdine, B. Lelouvier, K. Kilic, L. Liao, A. Nier, E. Latz, I. Bergheim, C. A. Thaiss, J. G. Hengstler, T. Strowig, C. Trautwein,
"Intestinal Dysbiosis Amplifies Acetaminophen-Induced Acute Liver Injury", Cellular and Molecular Gastroenterology and Hepatology, vol. 11, no. 4, 2021, pp. 909–933.
[bibtex] [url] [doi]
[14]C. V. Schneider, M. Kleinjans, M. Fromme, K. M. Schneider, P. Strnad,
"Phenome-wide association study in adult coeliac disease", Alimentary pharmacology & therapeutics, vol. 53, no. 4, 2021, pp. 510–518.
[bibtex] [url] [doi]
[15]A. Schippers, J. Hübel, F. Heymann, T. Clahsen, S. Eswaran, S. Schlepütz, R. Püllen, N. Gaßler, K. Tenbrock, F. Tacke, N. Wagner,
"MAdCAM-1/α4β7 Integrin-Mediated Lymphocyte/Endothelium Interactions Exacerbate Acute Immune-Mediated Hepatitis in Mice", Cellular and Molecular Gastroenterology and Hepatology, vol. 11, no. 4, 2021, pp. 1227–1250.el.
[bibtex] [url] [doi]
[16]S. Roohani, F. Tacke,
"Liver Injury and the Macrophage Issue", International journal of molecular sciences, vol. 22, no. 14, 2021, pp. 7249.
[bibtex] [url] [doi]
[17]A. Queck, F. E. Uschner, P. G. Ferstl, M. Schulz, M. J. Brol, M. Praktiknjo, R. Schierwagen, S. Klein, C. P. Strassburg, C. Meyer, C. Jansen, M. Berres, J. Trebicka,
"Role of circulating angiogenin levels in portal hypertension and TIPS", PLOS ONE, vol. 16, no. 8, 2021, pp. e0256473.
[bibtex] [url] [doi]
[18]M. Peiseler, F. Tacke,
"An Unexpected Line of Defense", Hepatology, 2021.
[bibtex] [url] [doi]
[19]M. Peiseler, F. Tacke,
"Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma", Cancers, vol. 13, no. 4, 2021, pp. 730.
[bibtex] [url] [doi]
[20]M. Muschaweck, L. Kopplin, F. Ticconi, A. Schippers, A. Iljazovic, E. J. C. Gálvez, A. T. Abdallah, N. Wagner, I. G. Costa, T. Strowig, O. Pabst,
"Cognate recognition of microbial antigens defines constricted CD4+ T cell receptor repertoires in the inflamed colon", Immunity, 2021.
[bibtex] [url] [doi]
[21]S. Monteiro, J. Grandt, F. E. Uschner, N. Kimer, J. L. Madsen, R. Schierwagen, S. Klein, C. Welsch, L. Schäfer, C. Jansen, J. Claria, J. Alcaraz-Quiles, V. Arroyo, R. Moreau, J. Fernandez, F. Bendtsen, G. Mehta, L. L. Gluud, S. Møller, M. Praktiknjo, J. Trebicka,
"Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation", Gut, vol. 70, 2021, pp. 379–387.
[bibtex] [url] [doi]
[22]B. Misselwitz, A. Wyss, T. Raselli, V. Cerovic, A. W. Sailer, N. Krupka, F. Ruiz, C. Pot, O. Pabst,
"The oxysterol receptor GPR183 in inflammatory bowel diseases", British journal of pharmacology, vol. 178, no. 16, 2021, pp. 3140–3156.
[bibtex] [url] [doi]
[23]C. Luciani, F. T. Hager, V. Cerovic, H. Lelouard,
"Dendritic cell functions in the inductive and effector sites of intestinal immunity", Mucosal immunology, 2021.
[bibtex] [url] [doi]
[24]J. Lambrecht, M. Porsch-Özçürümez, J. Best, F. Jost-Brinkmann, C. Roderburg, M. Demir, F. Tacke, R. Mohr,
"The APAC Score", Journal of Clinical Medicine, vol. 10, no. 15, 2021, pp. 3392.
[bibtex] [url] [doi]
[25]J. Lambrecht, F. Tacke,
"Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease", Frontiers in immunology, vol. 11, 2021, pp. 634409.
[bibtex] [url] [doi]
[26]B. Kurt, L. Bündgens, T. Wirtz, S. H. Loosen, M. Schulze-Hagen, D. Truhn, J. F. Brozat, S. Abu Jhaisha, P. Hohlstein, G. Koek, R. Weiskirchen, C. Trautwein, F. Tacke, K. Hamesch, A. Koch,
"Serum Perilipin 2 (PLIN2) Predicts Multiple Organ Dysfunction in Critically Ill Patients", Biomedicines, vol. 9, no. 9, 2021, pp. 1210.
[bibtex] [url] [doi]
[27]N. Kumar, T. C. A. Hitch, D. Haller, I. Lagkouvardos, T. Clavel,
"MiMiC: a bioinformatic approach for generation of synthetic communities from metagenomes", Microbial biotechnology, 2021, pp. 1–14.
[bibtex] [url] [doi]
[28]Y. Iwakiri, J. Trebicka,
"Portal hypertension in cirrhosis", JHEP reports, vol. 3, no. 4, 2021, pp. 100316.
[bibtex] [url] [doi]
[29]T. C. A. Hitch, T. Riedel, A. Oren, J. Overmann, T. D. Lawley, T. Clavel,
"Automated analysis of genomic sequences facilitates high-throughput and comprehensive description of bacteria", ISME communications, vol. 1, no. 1, 2021, pp. 16.
[bibtex] [url] [doi]
[30]P. Henneke, K. Kierdorf, L. J. Hall, M. Sperandio, M. W. Hornef,
"Perinatal development of innate immune topology", eLife, vol. 10, 2021, pp. e67793.
[bibtex] [url] [doi]
[31]D. Heinrichs, E. F. Brandt, P. Fischer, J. Köhncke, T. Wirtz, N. Guldiken, S. Djudjaj, P. Boor, D. C. Kroy, R. Weiskirchen, R. Bucala, H. E. Wasmuth, P. Strnad, C. Trautwein, J. Bernhagen, M. Berres,
"Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations", Cells, vol. 10, no. 2, 2021, pp. 252.
[bibtex] [url] [doi]
[32]D. A. Hausen, L. C. Bossert and U. Trautwein-Bruns,
"Aufgaben- und Kompetenzspektrum der Data Stewards an der RWTH Aachen University", Bausteine Forschungsdatenmanagement, vol. 3, 2021, pp. 92–105.
[bibtex] [url] [doi]
[33]M. Fulde, K. van Vorst, K. Zhang, A. J. Westermann, T. Busche, Y. C. Huei, K. Welitschanski, I. Froh, D. Pägelow, J. Plendl, C. Pfarrer, J. Kalinowski, J. Vogel, P. Valentin-Weigand, M. Hensel, K. Tedin, U. Repnik, M. W. Hornef,
"SPI2 T3SS effectors facilitate enterocyte apical to basolateral transmigration of Salmonella-containing vacuoles in vivo", Gut microbes, vol. 13, no. 1, 2021, pp. 1973836.
[bibtex] [url] [doi]
[34]S. Eswaran, A. Babbar, H. K. Drescher, T. C. A. Hitch, T. Clavel, M. Muschaweck, T. Ritz, D. C. Kroy, C. Trautwein, N. Wagner, A. Schippers,
"Upregulation of Anti-Oxidative Stress Response Improves Metabolic Changes in L-Selectin-Deficient Mice but Does Not Prevent NAFLD Progression or Fecal Microbiota Shifts", International journal of molecular sciences, vol. 22, no. 14, 2021, pp. 7314 pp..
[bibtex] [url] [doi]
[35]O. Estévez-Vázquez, R. Benedé-Ubieto, F. Guo, B. Gómez-Santos, P. Aspichueta, J. Reißing, T. Bruns, C. Sanz-García, S. Sydor, L. P. Bechmann, E. Maranillo, J. R. Sañudo, M. T. Vázquez, A. Lamas-Paz, L. Morán, M. S. Mazariegos, A. Ciudin, J. M. Pericàs, M. I. Peligros, J. Vaquero, E. Martínez-Naves, C. Liedtke, J. R. Regueiro, C. Trautwein, R. Bañares, F. J. Cubero, Y. A. Nevzorova,
"Fat", Biomedicines, vol. 9, no. 10, 2021, pp. 1289.
[bibtex] [url] [doi]
[36]A. Echle, N. T. Rindtorff, T. J. Brinker, T. Lüdde, A. T. Pearson, J. N. Kather,
"Deep learning in cancer pathology: a new generation of clinical biomarkers", British journal of cancer, vol. 124, no. 4, 2021, pp. 686–696.
[bibtex] [url] [doi]
[37]L. C. Bossert,
"CRC1382 and its DMP", 2021, pp. 113879064 Bytes.
[bibtex] [url] [doi]
[38]V. Baier, O. Clayton, R. Nudischer, H. Cordes, A. R. P. Schneider, C. W. J. Thiel, T. Wittenberger, W. Moritz, L. M. Blank, U. P. Neumann, C. Trautwein, J. Kelm, Y. Schrooders, F. Caiment, H. Gmuender, A. Roth, J. V. Castell, J. Kleinjans, L. O. Küpfer,
"A Model-Based Workflow to Benchmark the Clinical Cholestasis Risk of Drugs", Clinical pharmacology & therapeutics, vol. 110, no. 5, 2021, pp. 1293–1301.
[bibtex] [url] [doi]
[39]N. van Best, S. Trepels-Kottek, P. Savelkoul, T. Orlikowsky, M. W. Hornef, J. Penders,
"Influence of probiotic supplementation on the developing microbiota in human preterm neonates", Gut microbes, vol. 12, no. 1, 2020, pp. 1826747.
[bibtex] [url] [doi]
[40]N. van Best, U. Rolle-Kampczyk, F. G. Schaap, M. Basic, S. W. M. Olde Damink, A. Bleich, P. Savelkoul, M. von Bergen, J. Penders, M. W. Hornef,
"Bile acids drive the newborn’s gut microbiota maturation", Nature Communications, vol. 11, no. 1, 2020, pp. 3692.
[bibtex] [url] [doi]
[41]J. Zeng-Brouwers, S. Pandey, J. Trebicka, M. Wygrecka, L. Schaefer,
"Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune Diseases", Journal of histochemistry & cytochemistry, vol. 68, no. 12, 2020, pp. 887–906.
[bibtex] [url] [doi]
[42]T. Wirtz, L. Buendgens, R. Weiskirchen, S. H. Loosen, N. Haehnsen, T. Puengel, S. Abu Jhaisha, J. F. Brozat, P. Hohlstein, G. Koek, A. Eisert, R. Mohr, C. Roderburg, T. Lüdde, C. Trautwein, F. Tacke, A. Koch,
"Association of Serum Calprotectin Concentrations with Mortality in Critically Ill and Septic Patients", Diagnostics, vol. 10, no. 11, 2020.
[bibtex] [url] [doi]
[43]T. Wirtz, S. H. Loosen, L. Buendgens, B. Kurt, S. Abu Jhaisha, P. Hohlstein, J. F. Brozat, R. Weiskirchen, T. Lüdde, F. Tacke, C. Trautwein, C. Roderburg, A. Koch,
"Low Myostatin Serum Levels Are Associated with Poor Outcome in Critically Ill Patients", Diagnostics: open access journal, vol. 10, no. 8, 2020.
[bibtex] [url] [doi]
[44]S. Torres, Z. Abdullah, M. J. Brol, C. Hellerbrand, M. Fernandez, R. Fiorotto, S. Klein, P. Königshofer, C. Liedtke, S. Lotersztajn, Y. A. Nevzorova, R. Schierwagen, T. Reiberger, F. E. Uschner, F. Tacke, R. Weiskirchen, J. Trebicka,
"Recent Advances in Practical Methods for Liver Cell Biology", International journal of molecular sciences, vol. 21, no. 6, 2020, pp. 2027.
[bibtex] [url] [doi]
[45]M. Thiele, M. B. Hugger, Y. Kim, P. Rautou, L. Elkrief, C. Jansen, W. Verlinden, G. Allegretti, M. Israelsen, H. Stefanescu, F. Piscaglia, J. C. García-Pagán, S. Franque, A. Berzigotti, L. Castera, W. K. Jeong, J. Trebicka, A. Krag,
"2D shear wave liver elastography by aixplorer to detect portal hypertension in cirrhosis: an individual patient data meta-analysis", Liver international, vol. 40, no. 6, 2020, pp. 1435–1446.
[bibtex] [url] [doi]
[46]K. M. Schwarzkopf, L. Eberle, F. E. Uschner, S. Klein, R. Schierwagen, M. M. Mücke, L. Schaefer, J. Clària, S. Zeuzem, E. Hintermann, U. Christen, C. M. Lange, J. Trebicka, C. Welsch,
"Interleukin-22 in acute-on-chronic liver failure: A matter of ineffective levels, receptor dysregulation or defective signalling?", Journal of hepatology, vol. 73, no. 4, 2020, pp. 980–982.
[bibtex] [url] [doi]
[47]R. Schierwagen, P. Dietrich, S. Klein, F. E. Uschner, C. Ortiz, O. Tyc, S. Torres, C. Hellerbrand, T. Sauerbruch, J. Trebicka,
"β-Arrestin2 is increased in liver fibrosis in humans and rodents", Proceedings of the National Academy of Sciences of the United States of America, vol. 117, no. 44, 2020, pp. 27082–27084.
[bibtex] [url] [doi]
[48]R. Schierwagen, F. E. Uschner, C. Ortiz, S. Torres, M. J. Brol, O. Tyc, W. Gu, C. Grimm, S. Zeuzem, A. Plamper, P. Pfeifer, S. Zimmer, C. Welsch, L. Schaefer, K. P. Rheinwalt, J. Clària, V. Arroyo, J. Trebicka, S. Klein,
"The Role of Macrophage-Inducible C-Type Lectin in Different Stages of Chronic Liver Disease", Frontiers in immunology, vol. 11, 2020, pp. 1352.
[bibtex] [url] [doi]
[49]C. Roderburg, A. Wree, M. Demir, M. Schmelzle, F. Tacke,
"The role of the innate immune system in the development and treatment of hepatocellular carcinoma", Hepatic Oncology, vol. 7, no. 1, 2020, pp. 11 Seiten.
[bibtex] [url] [doi]
[50]A. Riba, K. Hassani, A. Walker, N. van Best, D. von Zeschwitz, T. Anslinger, N. Sillner, S. Rosenhain, D. Eibach, O. Maiga-Ascofaré, U. Rolle-Kampczyk, M. Basic, A. Binz, S. Mocek, B. Sodeik, R. Bauerfeind, A. Mohs, C. Trautwein, F. Kießling, J. May, M. Klingenspor, F. Gremse, P. Schmitt-Kopplin, A. Bleich, N. Torow, M. von Bergen, M. W. Hornef,
"Disturbed gut microbiota and bile homeostasis in Giardia-infected mice contributes to metabolic dysregulation and growth impairment", Science translational medicine, vol. 12, no. 565, 2020, pp. eaay7019.
[bibtex] [url] [doi]
[51]K. C. Reimer, A. Wree, C. Roderburg, F. Tacke,
"New drugs for NAFLD", Hepatology international, vol. 14, no. 1, 2020, pp. 8–23.
[bibtex] [url] [doi]
[52]A. Queck, H. Bode, F. E. Uschner, M. J. Brol, C. Graf, M. Schulz, C. Jansen, M. Praktiknjo, R. Schierwagen, S. Klein, C. Trautwein, H. E. Wasmuth, M. Berres, J. Trebicka, J. Lehmann,
"Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis", Frontiers in immunology, vol. 11, 2020, pp. 354.
[bibtex] [url] [doi]
[53]T. Puengel, F. Tacke,
"Editorial: prevalence, progression rates and mortality predictors of non-alcoholic fatty liver disease reflected by German statutory health insurance data", Alimentary pharmacology & therapeutics, vol. 52, no. 8, 2020, pp. 1412–1413.
[bibtex] [url] [doi]
[54]T. Puengel, S. De Vos, J. Hundertmark, M. Kohlhepp, N. Guldiken, P. Pujuguet, M. Auberval, F. Marsais, K. F. Shoji, L. Saniere, C. Trautwein, T. Lüdde, P. Strnad, R. Brys, P. Clément-Lacroix, F. Tacke,
"The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis", Journal of Clinical Medicine, vol. 9, no. 4, 2020, pp. 1140.
[bibtex] [url] [doi]
[55]R. Pieper, N. van Best, K. van Vorst, F. Ebner, M. Reissmann, M. W. Hornef, M. Fulde,
"Toward a porcine in vivo model to analyze the pathogenesis of TLR5-dependent enteropathies", Gut microbes, vol. 12, no. 1, 2020, pp. 1782163.
[bibtex] [url] [doi]
[56]F. C. Pereira, K. Wasmund, I. Cobankovic, N. Jehmlich, C. W. Herbold, K. S. Lee, B. Sziranyi, C. Vesely, T. Decker, R. Stocker, B. Warth, M. von Bergen, M. Wagner, D. Berry,
"Rational design of a microbial consortium of mucosal sugar utilizers reduces Clostridiodes difficile colonization", Nature Communications, vol. 11, 2020, pp. 5104.
[bibtex] [url] [doi]
[57]O. Pabst, E. Slack,
"IgA and the intestinal microbiota", Mucosal immunology, vol. 13, no. 1, 2020, pp. 12–21.
[bibtex] [url] [doi]
[58]J. C. Mossanen, T. U. Jansen, J. Pracht, A. Liepelt, L. Bündgens, C. Stoppe, A. Goetzenich, T. Simon, R. Autschbach, G. Marx, F. Tacke,
"Elevated circulating CD14++CD16+ intermediate monocytes are independently associated with extracardiac complications after cardiac surgery", Scientific reports, vol. 10, 2020, pp. 947.
[bibtex] [url] [doi]
[59]A. Mendler, A. Pierzchalski, M. Bauer, S. Röder, A. Sattler, M. Standl, M. Borte, M. von Bergen, U. Rolle-Kampczyk, G. Herberth,
"MAIT cell activation in adolescents is impacted by bile acid concentrations and body weight", Clinical and experimental immunology, vol. 200, no. 2, 2020, pp. 199–213.
[bibtex] [url] [doi]
[60]I. Lurje, L. Hammerich and F. Tacke,
"Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer", International journal of molecular sciences, vol. 21, no. 19, 2020, pp. 7378.
[bibtex] [url] [doi]
[61]A. Liepelt, P. Hohlstein, H. Gussen, J. Xue, A. C. Aschenbrenner, T. Ulas, L. Bündgens, K. T. Warzecha, M. Bartneck, T. Lüdde, C. Trautwein, J. L. Schultze, A. Koch, F. Tacke,
"Differential Gene Expression in Circulating CD14+ Monocytes Indicates the Prognosis of Critically Ill Patients with Sepsis", Journal of Clinical Medicine, vol. 9, no. 1, 2020, pp. 127.
[bibtex] [url] [doi]
[62]T. R. Lesker, A. C. Durairaj, E. J. C. Gálvez, I. Lagkouvardos, J. F. Baines, T. Clavel, A. Sczyrba, A. C. McHardy, T. Strowig,
"An Integrated Metagenome Catalog Reveals New Insights into the Murine Gut Microbiome", Cell reports, vol. 30, no. 9, 2020, pp. 2909–2922.e6.
[bibtex] [url] [doi]
[63]M. Lenicek, S. W. M. Olde Damink and F. G. Schaap,
"Gut Microbes Take It to the Next Level?", Hepatology, vol. 72, no. 4, 2020, pp. 1483–1485.
[bibtex] [url] [doi]
[64]S. Lefere, T. Püngel, J. Hundertmark, C. Penners, A. K. Frank, A. Guillot, K. de Muynck, F. Heymann, V. Adarbes, E. Defrêne, C. Estivalet, A. Geerts, L. Devisscher, G. Wettstein, F. Tacke,
"Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages", Journal of hepatology, vol. 73, no. 4, 2020, pp. 757–770.
[bibtex] [url] [doi]
[65]S. Lefere, L. Devisscher and F. Tacke,
"Targeting CCR2/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis", Expert opinion on investigational drugs, vol. 29, no. 2, 2020, pp. 89–92.
[bibtex] [url] [doi]
[66]J. Lambrecht, L. A. van Grunsven and F. Tacke,
"Current and emerging pharmacotherapeutic interventions for the treatment of liver fibrosis", Expert opinion on pharmacotherapy, vol. 21, no. 13, 2020, pp. 1637–1650.
[bibtex] [url] [doi]
[67]A. Lamas-Paz, L. Morán, J. Peng, B. Salinas, N. López-Alcántara, S. Sydor, R. Vilchez-Vargas, I. Asensio, F. Hao, K. Zheng, B. Martín-Adrados, L. Moreno, A. Cogolludo, M. Gómez del Moral, L. Bechmann, E. Martínez-Naves, J. Vaquero, R. Bañares, Y. A. Nevzorova, F. J. Cubero,
"Intestinal Epithelial Cell-Derived Extracellular Vesicles Modulate Hepatic Injury via the Gut-Liver Axis During Acute Alcohol Injury", Frontiers in pharmacology, vol. 11, 2020, pp. 603771.
[bibtex] [url] [doi]
[68]L. M. Klein, J. Chang, W. Gu, S. Manekeller, C. Jansen, P. Lingohr, M. Praktiknjo, J. C. Kalf, M. Schulz, U. Spengler, C. Strassburg, A. Cárdenas, V. Arroyo, J. Trebicka,
"The Development and Outcome of Acute-on-Chronic Liver Failure After Surgical Interventions", Liver transplantation, vol. 26, no. 2, 2020, pp. 227–237.
[bibtex] [url] [doi]
[69]J. Kabbert, J. Benckert, T. Rollenske, T. C. A. Hitch, T. Clavel, V. Cerovic, H. Wardemann, O. Pabst,
"High microbiota reactivity of adult human intestinal IgA requires somatic mutations", Journal of experimental medicine, vol. 217, no. 11, 2020, pp. e20200275.
[bibtex] [url] [doi]
[70]J. Hundertmark, F. Tacke,
"How effective are nonalcoholic fatty liver disease models for drug discovery?", Expert opinion on drug discovery, vol. 15, no. 11, 2020, pp. 1237–1240.
[bibtex] [url] [doi]
[71]M. W. Hornef, N. Torow,
"‘Layered immunity’ and the ‘neonatal window of opportunity’ - timed succession of non-redundant phases to establish mucosal host-microbial homeostasis after birth", Immunology, vol. 159, no. 1, 2020, pp. 15–25.
[bibtex] [url] [doi]
[72]J. Holmar, S. de la Puente-Secades, J. Floege, H. Noels, J. Jankowski, S. Orth-Alampour,
"Uremic Toxins Affecting Cardiovascular Calcification: A Systematic Review", Cells, vol. 9, no. 11, 2020, pp. 2428.
[bibtex] [url] [doi]
[73]A. Guillot, M. S. Kohlhepp, A. Bruneau, F. Heymann, F. Tacke,
"Deciphering the Immune Microenvironment on A Single Archival Formalin-Fixed Paraffin-Embedded Tissue Section by An Immediately Implementable Multiplex Fluorescence Immunostaining Protocol", Cancers, vol. 12, no. 9, 2020, pp. 2449.
[bibtex] [url] [doi]
[74]A. Guillot, F. Tacke,
"The Unexpected Role of Neutrophils for Resolving Liver Inflammation by Transmitting MicroRNA‐223 to Macrophages", Hepatology, vol. 71, no. 2, 2020, pp. 749–751.
[bibtex] [url] [doi]
[75]S. C. Ganal-Vonarburg, M. W. Hornef and A. J. Macpherson,
"Microbial-host molecular exchange and its functional consequences in early mammalian life", Science / Science now, vol. 368, no. 6491, 2020, pp. 604–607.
[bibtex] [url] [doi]
[76]H. K. Drescher, A. Schippers, S. Rosenhain, F. Gremse, L. Bongiovanni, A. de Bruin, S. Eswaran, S. U. Gallage, D. Pfister, M. Szydlowska, M. Heikenwalder, S. Weiskirchen, N. Wagner, C. Trautwein, R. Weiskirchen, D. C. Kroy,
"L-Selectin/CD62L is a Key Driver of Non-Alcoholic Steatohepatitis in Mice and Men", Cells, vol. 9, no. 5, 2020, pp. 1106.
[bibtex] [url] [doi]
[77]G. Cullaro, R. Sharma, J. Trebicka, A. Cárdenas, E. C. Verna,
"Precipitants of Acute‐on‐Chronic Liver Failure: An Opportunity for Preventative Measures to Improve Outcomes", Liver transplantation, vol. 26, no. 2, 2020, pp. 283–293.
[bibtex] [url] [doi]
[78]C. Cremonese, R. Schierwagen, F. E. Uschner, S. Torres, O. Tyc, C. Ortiz, M. Schulz, A. Queck, G. Kristiansen, M. Bader, T. Sauerbruch, R. Weiskirchen, T. Walther, J. Trebicka, S. Klein,
"Short-Term Western Diet Aggravates Non-Alcoholic Fatty Liver Disease (NAFLD) With Portal Hypertension in TGR(mREN2)27 Rats", International journal of molecular sciences, vol. 21, no. 9, 2020, pp. 3308.
[bibtex] [url] [doi]
[79]L. Buendgens, E. Yagmur, A. Ginsberg, R. Weiskirchen, T. Wirtz, S. A. Jhaisha, A. Eisert, T. Lüdde, C. Trautwein, F. Tacke, A. Koch,
"Midregional Proadrenomedullin (MRproADM) Serum Levels in Critically Ill Patients Are Associated with Short-Term and Overall Mortality during a Two-Year Follow-Up", Mediators of inflammation, vol. 2020, 2020, pp. 7184803.
[bibtex] [url] [doi]
[80]L. C. Bossert,
"Mit »biber –tool« Bibliografieeinträge bearbeiten", Die TEXnische Komödie, vol. 2, 2020, pp. 24–33.
[bibtex] [url] [doi]
[81]I. Biancacci, Q. Sun, D. Möckel, F. Gremse, S. Rosenhain, F. Kießling, M. Bartneck, Q. Hu, M. Thewissen, G. Storm, W. E. Hennink, Y. Shi, C. J. F. Rijcken, T. Lammers, A. M. Sofias,
"Optical imaging of the whole-body to cellular biodistribution of clinical-stage PEG-b-pHPMA-based core-crosslinked polymeric micelles", Journal of controlled release, vol. 328, 2020, pp. 805–816.
[bibtex] [url] [doi]
[82]F. Benz, A. Bogen, M. Praktiknjo, C. Jansen, C. Meyer, A. Wree, M. Demir, S. Loosen, M. Vucur, R. Schierwagen, F. Tacke, J. Trebicka, C. Roderburg,
"Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis", PLoS one, vol. 15, no. 4, 2020, pp. e0231701.
[bibtex] [url] [doi]
[83]M. Bartneck, C. Koppe, V. Fech, K. T. Warzecha, M. Kohlhepp, S. Huss, R. Weiskirchen, C. Trautwein, T. Lüdde, F. Tacke,
"Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With Liver Parenchymal Cell-Specific NEMO Deletion", Cellular and Molecular Gastroenterology and Hepatology, vol. 11, no. 2, 2020, pp. 327–347.
[bibtex] [url] [doi]
[84]S. Sutti, S. Bruzzì, F. Heymann, A. Liepelt, O. Krenkel, A. Toscani, N. Ramavath, D. Cotella, E. Albano, F. Tacke,
"CX3CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic Inflammation", Cells, vol. 8, no. 9, 2019, pp. 1099.
[bibtex] [url] [doi]
[85]A. Queck, D. Thomas, C. Jansen, Y. Schreiber, S. Rüschenbaum, M. Praktiknjo, K. M. Schwarzkopf, M. M. Mücke, R. Schierwagen, F. E. Uschner, C. Meyer, J. Clària, S. Zeuzem, G. Geisslinger, J. Trebicka, C. M. Lange,
"Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis", PLOS ONE, vol. 14, no. 10, 2019, pp. e0222840.
[bibtex] [url] [doi]
[86]S. Loosen, M. F. Schulze-Hagen, P. Bruners, F. Tacke, C. Trautwein, C. K. Kuhl, T. Lüdde, C. Roderburg,
"Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies", Cancers, vol. 11, no. 10, 2019, pp. 1503.
[bibtex] [url] [doi]
[87]G. Desalegn, O. Pabst,
"Inflammation triggers immediate rather than progressive changes in monocyte differentiation in the small intestine", Nature Communications, vol. 10, 2019, pp. 3229.
[bibtex] [url] [doi]
[88]A. Babbar, T. C. A. Hitch, O. Pabst, T. Clavel, J. Hübel, S. Eswaran, N. Wagner, A. Schippers,
"The Compromised Mucosal Immune System of β7 Integrin-Deficient Mice Has Only Minor Effects on the Fecal Microbiota in Homeostasis", Frontiers in microbiology, vol. 10, 2019, pp. 2284.
[bibtex] [url] [doi]